Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4952ba0242fe22f407a140f9dca46fc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf69cb35830eeb2bd7bd1e3b4c785442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9c55cbd632f124625c19c848aaffd9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7db5de82240bac0f5bfa94f0dcdfee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a08abe05f17b1a398cbc2a4f3f8ed507 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2839 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate |
2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176ed8df2c2324bbff19b74955241e79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74db55cbed61f30f5ec01575d58781e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3b8b50599bd5419d98b5e710284b4ef |
publicationDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011287007-A1 |
titleOfInvention |
Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6 |
abstract |
The present invention relates to methods of asthma treatment and prevention using α v β 6 antagonists, such as α v β 6 -binding antibodies. In particular, the invention relates to the discovery of a correlation between reduced expression of α v β 6 and the protection from the increase in airway sensitivity seen in chronic allergen-challenged mice. This protection is associated with protection from the usual allergen-induced increase in airway epithelial mast cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035859-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035860-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8992924-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9745376-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE44681-E |
priorityDate |
2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |